Wilbur A. Franklin

University of Colorado Denver, University of Colorado Health

Papers

Total Citations

127

H-Index

About

Wilbur A. Franklin is a prominent figure in lung cancer research, with a career focused on the molecular underpinnings of the disease and the translation of genomic insights into clinical practice. His most influential work centers on the role of KRAS mutations in non-small cell lung cancer, a landmark study published in 2009 that has garnered over 110 citations and helped define a critical driver of tumorigenesis. Franklin’s contributions extend to the pioneering field of molecular staging and pharmacogenomics, where his 2003 paper laid early groundwork for tailoring therapy based on individual genetic profiles. By integrating molecular markers into diagnostic frameworks, he has advanced the precision medicine approach that now guides treatment decisions for patients with lung cancer. His research has not only illuminated key pathways in tumor biology but also provided a foundation for developing targeted therapies, making him a key contributor to the shift from one-size-fits-all oncology to personalized care. For students and researchers, Franklin’s work exemplifies how bench-to-bedside research can directly impact patient outcomes, bridging the gap between laboratory discovery and clinical application.